Agenda

• Understanding Changes in the US ‘Heroin’ Market: Notes from the Field
  Daniel Ciccarone, MD, MPH
• The Evolving Epidemiology of HIV Infection in Persons Who Inject Drugs: Lessons Learned from Indiana 2015
  John T. Brooks, MD
• Conditions of Possibility: Harm Reduction as a Pathway to Healing the Harms Caused by Racialized Drug Policies
  Monique Tula
• Panel Discussion: Safe Consumption Spaces
  Alex H. Kral, PhD, Holly Bradford, MA
  Paula Lum, MD, MPH, Laura Thomas, MPP, MPH
• Clinical Interventions to Address the Opioid-Infectious Disease Syndemic
  Alexander Walley, MD, MSc
• Panel Discussion: Out of the Box Care for Persons who Use Drugs
  Andrew Herring, MD, Barry Zevin, MD, Pauli Gray, Pierre-Cedric Crouch, PhD, ANP-BC
• Moving Beyond MEDD and Opioids to Address the Opioid Crisis
  Elizabeth M. Oliva, PhD
• Unintended Consequences of the Opioid Epidemic on Clinician Practice
  Phillip Coffin, MD, MIA